These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3915962)

  • 1. Aluminium in continuous ambulatory peritoneal dialysis and post dilutional hemofiltration.
    Mion C
    Clin Nephrol; 1985; 24 Suppl 1():S88-93. PubMed ID: 3915962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elimination of aluminum via continuous ambulatory peritoneal dialysis].
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Dtsch Med Wochenschr; 1989 Jan; 114(1):9-13. PubMed ID: 2910699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium salts of keto-amino acids, a phosphate binder alternative for patients on CAPD.
    Macia M; Coronel F; Navarro JF; Gallego E; Herrero JA; Méndez ML; Chahin J; García J
    Clin Nephrol; 1997 Sep; 48(3):181-4. PubMed ID: 9342490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic aluminum poisoning in continuous ambulatory peritoneal dialysis: treatment with deferoxamine].
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Dtsch Med Wochenschr; 1989 Feb; 114(7):253-7. PubMed ID: 2917487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous ambulatory peritoneal dialysis: three years' experience.
    Ramos JM; Gokal R; Siamopolous K; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(206):165-86. PubMed ID: 6611839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.
    Takeda K; Nakamoto M; Baba M; Tanaka T; Yasunaga C; Nishihara G; Matsuo K; Urabe M
    Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing serum aluminum in CAPD patients.
    Montenegro J; Aguirre R; Saracho R; Moina I; Martínez I
    Clin Nephrol; 1998 Aug; 50(2):77-83. PubMed ID: 9725777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological aspects of aluminum poisoning in clinical nephrology.
    de Wolff FA
    Clin Nephrol; 1985; 24 Suppl 1():S9-14. PubMed ID: 3842105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of aluminum intoxication in chronic renal failure.
    Simon P; Allain P; Ang KS; Cam G; Mauras Y
    Adv Nephrol Necker Hosp; 1985; 14():439-78. PubMed ID: 3919543
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
    Canaud B; Mion C
    Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with continuous ambulatory peritoneal dialysis (CAPD) at the University Clinic for Internal Medicine in Innsbruck].
    König P; Spielberger M; Vogel W; Dittrich P
    Wien Klin Wochenschr; 1983 Mar; 95(5):168-71. PubMed ID: 6858173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.
    Tang SC; Lam B; Ku PP; Leung WS; Chu CM; Ho YW; Ip MS; Lai KN
    J Am Soc Nephrol; 2006 Sep; 17(9):2607-16. PubMed ID: 16885414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hemodynamic effect of calcium ion concentration in the infusate during predilution hemofiltration in chronic renal failure.
    Karamperis N; Sloth E; Jensen JD
    Am J Kidney Dis; 2005 Sep; 46(3):470-80. PubMed ID: 16129209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-volume supine peritoneal dialysis in a chronic obstructive airway disease patient.
    Bhatla B; Satalowich R; Khanna R
    Adv Perit Dial; 1994; 10():120-3. PubMed ID: 7999808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between serum aluminum concentration and signs of encephalopathy in a large population of patients dialyzed with aluminum-free fluids.
    Rovelli E; Luciani L; Pagani C; Albonico C; Colleoni N; D'Amico G
    Clin Nephrol; 1988 Jun; 29(6):294-8. PubMed ID: 3396232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.